IONS Ionis Pharmaceuticals, Inc. Common Stock Loading...

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
18:49
Sep 04
psyduckcapital
Added more IONS
Added more to an existing Ionis Pharmaceuticals position; no reason is given.
IONS Ionis Pharmaceuticals, Inc. Common Stock Long Position: Added —
16:10
Aug 01
psyduckcapital
IONS remains undervalued here
States that Ionis remains undervalued at current levels, responding to a comparison of its drug franchise with a similarly valued peer.
IONS Ionis Pharmaceuticals, Inc. Common Stock Long — —
18:26
Jul 27
psyduckcapital
Added marginally to IONS again
Added marginally again to his existing IONS position at current levels, alongside three other biotech holdings.
IONS Ionis Pharmaceuticals, Inc. Common Stock Long 1ST Position: Added —

About IONS Investor Commentary

Across the available history and selected sources, Buzzberg tracks IONS (Ionis Pharmaceuticals, Inc. Common Stock) across 10 sources: 3 bullish vs 0 bearish calls from 10 authors. Historical directional balance: 20% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 15 total trade ideas tracked. Latest voices: psyduckcapital.